The leukemic stem cell

Por Jordan, Craig T.
Publicado em 2007

Can we finally target the leukemic stem cells?

Por Jordan, Craig T.
Publicado em 2008

Cancer Stem Cells: Controversial or Just Misunderstood?

Por Jordan, Craig T.
Publicado em 2009

The Increasing Complexity of the Cancer Stem Cell Paradigm

Por Rosen, Jeffrey M., Jordan, Craig T.
Publicado em 2009

Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting

Por Konopleva, Marina Y., Jordan, Craig T.
Publicado no J Clin Oncol (2011)

A test of homogeneity for age-dependent branching processes with immigration

Por Hyrien, Ollivier, Yanev, Nikolay M., Jordan, Craig T.
Publicado no Electron J Stat (2015)

Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: A model for latency

Por Goodrum, Felicia D., Jordan, Craig T., High, Kevin, Shenk, Thomas
Publicado em 2002

Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture

Por Nasim, Shama, Guzman, Monica L., Jordan, Craig T., Crooks, Peter A.
Publicado em 2011

Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C—H functionalization

Por Kolev, Joshua N., O’Dwyer, Kristen M., Jordan, Craig T., Fasan, Rudi
Publicado em 2013

Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials

Por Pollyea, Daniel A., Gutman, Jonathan A., Gore, Lia, Smith, Clayton A., Jordan, Craig T.
Publicado em 2014

Non-canonical NF-κB signaling regulates hematopoietic stem cell self-renewal and microenvironment interactions

Por Zhao, Chen, Xiu, Yan, Ashton, John, Xing, Lianping, Morita, Yoshikazu, Jordan, Craig T., Boyce, Brendan F.
Publicado em 2012

A Novel In Vitro Assay of Tumor-Initiating Cells in Xenograft Prostate Tumors

Por Silvers, Christopher R., Williams, Karin, Salamone, Linda, Huang, Jiaoti, Jordan, Craig T., Zhou, Haijun, Palapattu, Ganesh S.
Publicado em 2010

Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity

Por Sen, Siddhartha, Hassane, Duane C., Corbett, Cheryl, Becker, Michael W., Jordan, Craig T., Guzman, Monica L.
Publicado em 2013

Dimers of melampomagnolide B exhibit potent anticancer activity against hematological and solid tumor cells

Por Janganati, Venumadhav, Ponder, Jessica, Jordan, Craig T., Borrelli, Michael J., Penthala, Narsimha Reddy, Crooks, Peter A.
Publicado no J Med Chem (2015)

Eukaryotic Translation Initiation Factor 4E Activity Is Modulated by HOXA9 at Multiple Levels

Por Topisirovic, Ivan, Kentsis, Alex, Perez, Jacqueline M., Guzman, Monica L., Jordan, Craig T., Borden, Katherine L. B.
Publicado em 2005

Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia

Por Frisch, Benjamin J., Ashton, John M., Xing, Lianping, Becker, Michael W., Jordan, Craig T., Calvi, Laura M.
Publicado em 2012

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

Por Guzman, Monica L., Rossi, Randall M., Karnischky, Lilliana, Li, Xiaojie, Peterson, Derick R., Howard, Dianna S., Jordan, Craig T.
Publicado em 2005

A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia

Por Howard, Dianna S., Liesveld, Jane, II, Gordon L. Phillips, Hayslip, John, Weiss, Heidi, Jordan, Craig T., Guzman, Monica L.
Publicado em 2013

Chemoenzymatic synthesis and antileukemic activity of novel C9- and C14-functionalized parthenolide analogs

Por Tyagi, Vikas, Alwaseem, Hanan, O’Dwyer, Kristen M., Ponder, Jessica, Li, Qi Ying, Jordan, Craig T., Fasan, Rudi
Publicado no Bioorg Med Chem (2016)

Design, synthesis and evaluation of anti-CD123 antibody drug conjugates

Por Li, Bin, Zhao, Weiyu, Zhang, Xinfu, Wang, Junfeng, Luo, Xiao, Baker, Sharyn D., Jordan, Craig T., Dong, Yizhou
Publicado no Bioorg Med Chem (2016)